AMGN vs. BTQ.NEO

Last updated Jun 13, 2026

AMGN (Amgen Inc.) and BTQ.NEO (BTQ Technologies Corp) are both stocks. AMGN operates in Drug Manufacturers - General (Healthcare), while BTQ.NEO operates in Software - Infrastructure (Technology). Over the past 3 years, AMGN returned 20.61%/yr vs 98.36%/yr for BTQ.NEO. At a 0.02 correlation, their price movements are largely independent.

Performance

AMGN vs. BTQ.NEO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Amgen Inc. (AMGN) and BTQ Technologies Corp (BTQ.NEO). The values are adjusted to include any dividend payments, if applicable.

Different Trading Currencies

AMGN is traded in USD, while BTQ.NEO is traded in CAD. To make them comparable, the BTQ.NEO values have been converted to USD using the latest available exchange rates.

Returns By Period

In the year-to-date period, AMGN achieves a 10.10% return, which is significantly higher than BTQ.NEO's -19.90% return.

AMGN

• 1D: 0.32%
• 1M: 6.37%
• YTD: 10.10%
• 6M: 13.41%
• 1Y: 23.07%
• 3Y*: 20.61%
• 5Y*: 11.36%
• 10Y*: 12.08%

BTQ.NEO

• 1D: -5.50%
• 1M: 29.09%
• YTD: -19.90%
• 6M: -30.34%
• 1Y: 22.13%
• 3Y*: 98.36%
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

AMGN vs. BTQ.NEO - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023
AMGN Amgen Inc.	10.10%	29.67%	-6.77%	22.81%
BTQ.NEO BTQ Technologies Corp	-19.90%	88.56%	342.98%	11.18%

Correlation

The correlation between AMGN and BTQ.NEO is 0.12, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.12
Correlation (3Y) Calculated over the trailing 3-year period	0.03
Correlation (All Time) Calculated using the full available price history since Feb 21, 2023	0.02

Fundamentals

Market Cap AMGN : $193.23B BTQ.NEO : CA$799.35M
EPS AMGN : $14.38 BTQ.NEO : -CA$0.11
PS Ratio AMGN : 5.17 BTQ.NEO : 1.39K
PB Ratio AMGN : 21.03 BTQ.NEO : 20.97
Total Revenue (TTM) AMGN : $37.24B BTQ.NEO : CA$565.50K
Gross Profit (TTM) AMGN : $26.61B BTQ.NEO : CA$565.50K
EBITDA (TTM) AMGN : $17.27B BTQ.NEO : -CA$14.23M

Return for Risk

AMGN vs. BTQ.NEO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

AMGN

AMGN Risk / Return Rank: 68
AMGN Sharpe Ratio Rank: 70
AMGN Sortino Ratio Rank: 66
AMGN Omega Ratio Rank: 64
AMGN Calmar Ratio Rank: 70
AMGN Martin Ratio Rank: 69

BTQ.NEO

BTQ.NEO Risk / Return Rank: 55
BTQ.NEO Sharpe Ratio Rank: 48
BTQ.NEO Sortino Ratio Rank: 69
BTQ.NEO Omega Ratio Rank: 62
BTQ.NEO Calmar Ratio Rank: 50
BTQ.NEO Martin Ratio Rank: 47

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

AMGN vs. BTQ.NEO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Amgen Inc. (AMGN) and BTQ Technologies Corp (BTQ.NEO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	AMGN	BTQ.NEO	Difference
Sharpe ratio: Return per unit of total volatility	0.84	0.14	+0.70
Sortino ratio: Return per unit of downside risk	1.42	1.60	-0.18
Omega ratio: Gain probability vs. loss probability	1.17	1.16	+0.01
Calmar ratio: Return relative to maximum drawdown	1.40	0.26	+1.13
Martin ratio: Return relative to average drawdown	3.22	0.37	+2.85

AMGN vs. BTQ.NEO - Sharpe Ratio Comparison

The current AMGN Sharpe Ratio is 0.84, which is higher than the BTQ.NEO Sharpe Ratio of 0.14. The chart below compares the historical Sharpe Ratios of AMGN and BTQ.NEO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

AMGN vs. BTQ.NEO - Drawdown Comparison

The maximum AMGN drawdown since its inception was -63.48%, smaller than the maximum BTQ.NEO drawdown of -84.79%. Use the drawdown chart below to compare losses from any high point for AMGN and BTQ.NEO.

Drawdown Indicators

	AMGN	BTQ.NEO	Difference
Max Drawdown Largest peak-to-trough decline	-63.48%	-84.79%	+21.31%
Max Drawdown (1Y) Largest decline over 1 year	-16.57%	-84.79%	+68.22%
Max Drawdown (3Y) Largest decline over 3 years	-22.74%	-84.79%	+62.05%
Max Drawdown (5Y) Largest decline over 5 years	-24.86%	—	—
Max Drawdown (10Y) Largest decline over 10 years	-24.86%	—	—
Current Drawdown Current decline from peak	-7.80%	-70.78%	+62.98%
Average Drawdown Average peak-to-trough decline	-16.77%	-47.36%	+30.59%
Ulcer Index Depth and duration of drawdowns from previous peaks	7.19%	59.76%	-52.57%

Volatility

AMGN vs. BTQ.NEO - Volatility Comparison

The current volatility for Amgen Inc. (AMGN) is 7.92%, while BTQ Technologies Corp (BTQ.NEO) has a volatility of 42.41%. This indicates that AMGN experiences smaller price fluctuations and is considered to be less risky than BTQ.NEO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	AMGN	BTQ.NEO	Difference
Volatility (1M) Calculated over the trailing 1-month period	7.92%	42.41%	-34.49%
Volatility (6M) Calculated over the trailing 6-month period	19.22%	84.89%	-65.67%
Volatility (1Y) Calculated over the trailing 1-year period	27.79%	161.46%	-133.67%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	23.97%	171.66%	-147.69%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	24.86%	171.66%	-146.80%

Dividends

AMGN vs. BTQ.NEO - Dividend Comparison

AMGN's dividend yield for the trailing twelve months is around 2.76%, while BTQ.NEO has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
AMGN Amgen Inc.	2.76%	2.91%	3.45%	2.96%	2.95%	3.13%	2.78%	2.41%	2.71%	2.65%	2.74%	1.95%
BTQ.NEO BTQ Technologies Corp	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials

Frequently Asked Questions

Can I hold both AMGN and BTQ.NEO in my portfolio?

AMGN and BTQ.NEO have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.